Stay updated on Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.

Latest updates to the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRecruitment status on the study page indicates that enrollment is closed. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment label was adjusted, and the site revision was updated to v3.6.0.SummaryDifference0.3%

- Check21 days agoChange DetectedThe page now displays a new revision label (v3.5.5) replacing the previous v3.5.4, indicating a minor version update without changes to the study content.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4. This appears to be an administrative version update rather than a change to the study content.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision: v3.5.3 was added and the previous 'Revision: v3.5.2' was removed, signaling a minor platform update. This is a versioning change rather than a modification to study content or results.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No visible changes to study details or page content.SummaryDifference0.0%

- Check100 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 on the page.SummaryDifference0.0%

Stay in the know with updates to Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tipifarnib in HRAS-Mutant Squamous Head and Neck Cancer Clinical Trial page.